Aging and endothelin: Determinants of disease

Life Sciences

Volumn 118, Issue 2, 2014, Pages 97-109

  Barton, Matthias ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Aged; Aging; Angiotenin converting enzyme inhibitor; Angiotensin; Angiotensin receptor blocker; ARB; Awareness; Cancer; Childhood; Chronic disease; CKD; Coronary artery disease; Diabetes; Education; Endothelin receptor antagonist; ERA; FSGS; Glomerulosclerosis; Health; Healthy aging; Heart failure; Hypertension; MMM; Modifiable molecular mediator; Obesity; Parents; Prevention; Renal disease; Schools; Senescence; Sydenham; Telomeres; Thomas

Indexed keywords

ENDOTHELIN;

AGING; BIOLOGICAL MODEL; CHRONIC DISEASE; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; METABOLISM;

AGING; CHRONIC DISEASE; ENDOTHELIAL CELLS; ENDOTHELINS; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL;

EID: 84920757746     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.09.009     Document Type: Review

References (201)

1. M. Adamczak, M.L. Gross, J. Krtil, A. Koch, K. Tyralla, and K. Amann Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats J Am Soc Nephrol 14 2003 2833 2842
2. M. Adamczak, M.L. Gross, K. Amann, and E. Ritz Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature J Am Soc Nephrol 15 2004 3063 3072
3. V. Adams, C. Besler, T. Fischer, M. Riwanto, F. Noack, and R. Hollriegel Exercise training in patients with chronic heart failure promotes restoration of high-density lipoprotein functional properties Circ Res 113 2013 1345 1355
4. R. Altschul Endothelium: its development, morphology, function, and pathology 1954 Macmillan Co. New York 1 145
5. D. Aw, A.B. Silva, and D.B. Palmer Immunosenescence: emerging challenges for an ageing population Immunology 120 2007 435 446
6. M. Barton Ageing as a determinant of renal and vascular disease: role of endothelial factors Nephrol Dial Transplant 20 2005 485 490
7. M. Barton Aging and biomedicine 2005: where should we go from here? Cardiovasc Res 66 2005 187 189
8. M. Barton Reversal of proteinuric renal disease and the emerging role of endothelin Nat Clin Pract Nephrol 4 2008 490 501
9. M. Barton Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis Pflugers Arch 460 2010 825 837
10. M. Barton The discovery of endothelium-dependent contraction: the legacy of Paul M. Vanhoutte Pharmacol Res 63 2011 455 462
11. M. Barton Childhood obesity: a life-long health risk Acta Pharmacol Sin 33 2012 189 193
12. M. Barton Childhood obesity: preventing today's children from becoming tomorrow's patients IFAVA Sci Newsl 75 2013 1
13. M. Barton Cholesterol and atherosclerosis: modulation by oestrogen Curr Opin Lipidol 24 2013 214 220
14. M. Barton Mechanisms and therapy of atherosclerosis and its clinical complications Curr Opin Pharmacol 13 2013 149 153
15. M. Barton Prevention and endothelial therapy of coronary artery disease Curr Opin Pharmacol 13 2013 226 241
16. M. Barton, and J. Furrer Cardiovascular consequences of the obesity pandemic: need for action Expert Opin Investig Drugs 12 2003 1757 1759
17. M. Barton, and C.C. Haudenschild Endothelium and atherogenesis: endothelial therapy revisited J Cardiovasc Pharmacol 38 Suppl. 2 2001 S23 S25
18. M. Barton, and W. Kiowski The therapeutic potential of endothelin receptor antagonists in cardiovascular disease Curr Hypertens Rep 3 2001 322 330
19. M. Barton, and T.F. Luscher Endothelin antagonists for hypertension and renal disease Curr Opin Nephrol Hypertens 8 1999 549 556
20. M. Barton, and M.R. Meyer Postmenopausal hypertension: mechanisms and therapy Hypertension 54 2009 11 18
21. M. Barton, and D.M. Pollock The future of endothelin research: scientific mentoring and beyond Life Sci 91 2012 470 474
22. M. Barton, and M. Yanagisawa Endothelin: 20 years from discovery to therapy Can J Physiol Pharmacol 86 2008 485 498
23. A receptors for endothelin regulation Biochem Biophys Res Commun 238 1997 861 865
24. M. Barton, F. Cosentino, R.P. Brandes, P. Moreau, S. Shaw, and T.F. Luscher Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin Hypertension 30 1997 817 824
25. M. Barton, T. Lattmann, L.V. d'Uscio, T.F. Luscher, and S. Shaw Inverse regulation of endothelin-1 and nitric oxide metabolites in tissue with aging: implications for the age-dependent increase of cardiorenal disease J Cardiovasc Pharmacol 36 2000 S153 S156
26. M. Barton, R. Carmona, H. Morawietz, L.V. d'Uscio, W. Goettsch, and H. Hillen Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin Hypertension 35 2000 329 336
27. M. Barton, P.C. Nett, K. Amann, and M.M. Teixeira Anti-inflammatory effects of endothelin receptor antagonists and their importance for treating human disease Front Cardiovasc Drug Discov 1 2010 236 258
28. M. Barton, O. Baretella, and M.R. Meyer Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction Br J Pharmacol 165 2012 591 602
29. C. Baylis, and B. Corman The aging kidney: insights from experimental studies J Am Soc Nephrol 9 1998 699 709
30. C. Baylis, and R. Schmidt The aging glomerulus Semin Nephrol 16 1996 265 276
31. C.M. Beauséjour, A. Krtolica, F. Galimi, M. Narita, S.W. Lowe, and P. Yaswen Reversal of human cellular senescence: roles of the p53 and p16 pathways EMBO J 22 2003 4212 4222
32. E. Bendiner Thomas Sydenham: 'the English Hippocrates' Hosp Pract (Off Ed) 21 1986 [183-9, 93-7, 201-13]
33. A. Benigni, D. Corna, C. Zoja, A. Sonzogni, R. Latini, and M. Salio Disruption of the Ang II type 1 receptor promotes longevity in mice J Clin Invest 119 2009 524 530
34. I. Bhattacharya, M. Damjanovic, A. Gut, S. Hager, A. Perez Dominguez, and A. Minotti Childhood obesity induced by a high-fat diet causes premature vascular aging involving endothelium-dependent mechanisms Hypertension 52 2008 e89
35. J.J. Boffa, P.L. Tharaux, J.C. Dussaule, and C. Chatziantoniou Regression of renal vascular fibrosis by endothelin receptor antagonism Hypertension 37 2001 490 496
36. D. Bolignano, F. Mattace-Raso, E.J. Sijbrands, and C. Zoccali The aging kidney revisited: a systematic review Ageing Res Rev 14 2014 65 80
37. D. Boraschi, G. Del Giudice, C. Dutel, B. Ivanoff, R. Rappuoli, and B. Grubeck-Loebenstein Ageing and immunity: addressing immune senescence to ensure healthy ageing Vaccine 28 2010 3627 3631
38. P. Bramlage, D. Pittrow, H.U. Wittchen, W. Kirch, S. Boehler, and H. Lehnert Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled Am J Hypertens 17 2004 904 910
39. R.P. Brandes, I. Fleming, and R. Busse Endothelial aging Cardiovasc Res 66 2005 286 294
40. R.P. Brandes, N. Weissmann, and K. Schroder NADPH oxidases in cardiovascular disease Free Radic Biol Med 49 2010 687 706
41. S.V. Brodsky, O. Gealekman, J. Chen, F. Zhang, N. Togashi, and M. Crabtree Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen Circ Res 94 2004 377 384
42. J.H. Brooks, and A. Ferro The physician's role in prescribing physical activity for the prevention and treatment of essential hypertension JRSM Cardiovasc Dis 1 2012
43. H. Bruunsgaard, K. Andersen-Ranberg, J. Hjelmborg, B.K. Pedersen, and B. Jeune Elevated levels of tumor necrosis factor alpha and mortality in centenarians Am J Med 115 2003 278 283
44. G.G. Bural, D.A. Torigian, S. Basu, M.F. Bozkurt, M. Houseni, and A. Alavi Atherosclerotic inflammatory activity in the aorta and its correlation with aging and gender as assessed by 18F-FDG-PET Hell J Nucl Med 16 2013 164 168
45. U. Campia, M. Tesauro, N. Di Daniele, and C. Cardillo The vascular endothelin system in obesity and type 2 diabetes: Pathophysiology and therapeutic implications Life Sci 118 2014 149 155 [in this issue]
46. B.C. Capell, F.S. Collins, and E.G. Nabel Mechanisms of cardiovascular disease in accelerated aging syndromes Circ Res 101 2007 13 26
47. J. Campisi Cell biology: The beginning of the end Nature 505 2014 35 36
48. T. Caulin-Glaser, J. Falko, L. Hindman, M. La Londe, and R. Snow Cardiac rehabilitation is associated with an improvement in C-reactive protein levels in both men and women with cardiovascular disease J Cardiopulm Rehabil 25 2005 332 336 [quiz 7-8]
49. J. Chen, and W.J. Millar Health effects of physical activity Health Rep 11 1999 [21-30(Eng); 21-31(Fre)]
50. H.Y. Chung, M. Cesari, S. Anton, E. Marzetti, S. Giovannini, and A.Y. Seo Molecular inflammation: underpinnings of aging and age-related diseases Ageing Res Rev 8 2009 18 30
51. J. Cockcroft, and G. Mancia Vascular aging: shifting the paradigm of risk assessment and reduction in hypertension J Hypertens 30 2012 S1 S2 [Suppl.]
52. A. Csiszar, Z. Ungvari, A. Koller, J.G. Edwards, and G. Kaley Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries FASEB J 17 2003 1183 1185
53. A. Csiszar, Z. Ungvari, A. Koller, J.G. Edwards, and G. Kaley Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging Physiol Genomics 17 2004 21 30
54. J.G. de Mey, and P.M. Vanhoutte Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium Circ Res 51 1982 439 447
55. A.J. Donato, L.A. Lesniewski, and M.D. Delp The effects of aging and exercise training on endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles Cardiovasc Res 66 2005 393 401
56. A.J. Donato, L.B. Gano, I. Eskurza, A.E. Silver, P.E. Gates, and K. Jablonski Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase Am J Physiol Heart Circ Physiol 297 2009 H425 H432
57. H.J. Dong, E. Wressle, and J. Marcusson Multimorbidity patterns of and use of health services by Swedish 85-year-olds: an exploratory study BMC Geriatr 13 2013 120
58. K. Dorshkind, and S. Swain Age-associated declines in immune system development and function: causes, consequences, and reversal Curr Opin Immunol 21 2009 404 407
59. A. Drewnowski, and W.J. Evans Nutrition, physical activity, and quality of life in older adults: summary J Gerontol A Biol Sci Med Sci 56 Spec No 2 2001 89 94
60. L.V. d'Uscio, S. Shaw, M. Barton, and T.F. Luscher Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function Hypertension 31 1998 1305 1310
61. V.J. Dzau Significance of the vascular renin-angiotensin pathway Hypertension 8 1986 553 559
62. H. Ehrenreich, R.W. Anderson, C.H. Fox, P. Rieckmann, G.S. Hoffman, and W.D. Travis Endothelins, peptides with potent vasocactive properties, are produced by human macrophages J Exp Med 172 1990 1741 1748
63. M. El Assar, J. Angulo, S. Vallejo, C. Peiro, C.F. Sanchez-Ferrer, and L. Rodriguez-Manas Mechanisms involved in the aging-induced vascular dysfunction Front Physiol 3 2012 132
64. A.A. Elesber, P.O. Bonetti, J.E. Woodrum, X.Y. Zhu, L.O. Lerman, and S.G. Younkin Bosentan preserves endothelial function in mice overexpressing APP Neurobiol Aging 27 2006 446 450
65. Exercise Medicine Initiative Exercise is medicine - the global initiative URL: http://www.exerciseismedicine.org/global.htm 2014 [accessed September 10, 2014]
66. S. Fedoroff Rudolf Altschul: man and scientist A.I. Gotlieb, B.L. Langill, Atherosclerosis: cellular and molecular interactions in the artery wall 1991 Plenum Press New York 1 7
67. L. Ferrucci, A. Corsi, F. Lauretani, S. Bandinelli, B. Bartali, and D.D. Taub The origins of age-related proinflammatory state Blood 105 2005 2294 2299
68. B. Folkow, and A. Svanborg Physiology of cardiovascular aging Physiol Rev 73 1993 725 764
69. C. Franceschi, M. Bonafe, S. Valensin, F. Olivieri, M. De Luca, and E. Ottaviani Inflamm-aging. An evolutionary perspective on immunosenescence Ann N Y Acad Sci 908 2000 244 254
70. S.S. Franklin, and G.L. Pierce Cardiorespiratory fitness and the attenuation of age-related rise in blood pressure: an important role for effective primordial prevention J Am Coll Cardiol 64 2014 1254 1256
71. R.F. Furchgott The pharmacology of vascular smooth muscle Pharmacol Rev 7 1955 183 265
72. R.F. Furchgott The discovery of endothelium-dependent relaxation Circulation 87 Suppl. V 1993 V3 V8
73. R.F. Furchgott A research trail over half a century Annu Rev Pharmacol Toxicol 35 1995 1 27
74. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 299 1980 373 376
75. J.J. Fuster, J. Diez, and V. Andres Telomere dysfunction in hypertension J Hypertens 25 2007 2185 2192
76. P. Gerland, and A.E. Raftery Ševcíková H, Li N, Gu G, Spoorenberg T, et al 2014 Science World population stabilization unlikely this century http://dx.doi.org/10.1126/science.1257469 [Published online September 18]
77. S. Gielen, C. Walther, G. Schuler, and R. Hambrecht Anti-inflammatory effects of physical exercise. A new mechanism to explain the benefits of cardiac rehabilitation? J Cardiopulm Rehabil 25 2005 339 342
78. S. Gielen, R. Hambrecht, and G.C. Schuler Commentary on viewpoint: exercise and cardiovascular risk reduction: time to update the rationale for exercise? J Appl Physiol (1985) 105 2008 771
79. T.D. Girard, and E.W. Ely Bacteremia and sepsis in older adults Clin Geriatr Med 23 2007 633 647 [viii]
80. A. Goel, B. Su, S. Flavahan, C.J. Lowenstein, D.E. Berkowitz, and N.A. Flavahan Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries Circ Res 107 2010 242 251
81. W. Goettsch, T. Lattmann, K. Amann, M. Szibor, H. Morawietz, and K. Munter Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis Biochem Biophys Res Commun 280 2001 908 913
82. D.J. Green, G. O'Driscoll, M.J. Joyner, and N.T. Cable Exercise and cardiovascular risk reduction: time to update the rationale for exercise? J Appl Physiol (1985) 105 2008 766 768
83. A.L. Gruver, L.L. Hudson, and G.D. Sempowski Immunosenescence of ageing J Pathol 211 2007 144 156
84. T.J. Guzik, N.E. Hoch, K.A. Brown, L.A. McCann, A. Rahman, and S. Dikalov Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction J Exp Med 204 2007 2449 2460
85. H. Hanke, C. Lenz, and G. Finking The discovery of the pathophysiological aspects of atherosclerosis - a review Acta Chir Belg 101 2001 162 169
86. D. Harman The aging process: major risk factor for disease and death Proc Natl Acad Sci U S A 88 1991 5360 5363
87. D. Harman Free radical theory of aging: history EXS 62 1992 1 10
88. D. Harman Aging and disease: extending functional life span Ann N Y Acad Sci 786 1996 321 336
89. V.J. Harrison, K. Barnes, A.J. Turner, E. Wood, R. Corder, and J.R. Vane Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells Proc Natl Acad Sci U S A 92 1995 6344 6348
90. D.G. Harrison, P.J. Marvar, and J.M. Titze Vascular inflammatory cells in hypertension Front Physiol 3 2012 128
91. W.L. Haskell, I.M. Lee, R.R. Pate, K.E. Powell, S.N. Blair, and B.A. Franklin Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association Circulation 116 2007 1081 1093
92. T. Hayashi, K. Yano, H. Matsui-Hirai, H. Yokoo, Y. Hattori, and A. Iguchi Nitric oxide and endothelial cellular senescence Pharmacol Ther 120 2008 333 339
93. M.L. Hellenius, and C.J. Sundberg Physical activity as medicine: time to translate evidence into clinical practice Br J Sports Med 45 2011 158
94. O. Hernandez-Perera, D. Perez-Sala, J. Navarro-Antolin, R. Sanchez-Pascuala, G. Hernandez, and C. Diaz Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells J Clin Invest 101 1998 2711 2719
95. K.A. Hickey, G.M. Rubanyi, R.J. Paul, and R.F. Highsmith Characterization of a coronary vasoconstrictor produced by cultured endothelial cells Am J Physiol 248 1985 C550 C556
96. H. Holstege, W. Pfeiffer, D. Sie, M. Hulsman, T.J. Nicholas, and C.C. Lee Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis Genome Res 24 2014 733 742
97. T.K. Howcroft, J. Campisi, G.B. Louis, M.T. Smith, B. Wise, and T. Wyss-Coray The role of inflammation in age-related disease Aging (Albany NY) 5 2013 84 93
98. L.J. Ignarro, G.M. Buga, K.S. Wood, R.E. Byrns, and G. Chaudhuri Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide Proc Natl Acad Sci U S A 84 1987 9265 9269
99. R.M. Kedzierski, and M. Yanagisawa Endothelin system: the double-edged sword in health and disease Annu Rev Pharmacol Toxicol 41 2001 851 876
100. D.E. Kohan, and M. Barton Endothelin and endothelin antagonists in chronic kidney disease Kidney Int 86 2014 896 904 http://dx.doi.org/10.1038/ki.2014.143
101. D.E. Kohan, E.W. Inscho, D. Wesson, and D.M. Pollock Physiology of endothelin and the kidney Compr Physiol 1 2011 883 919
102. D.E. Kohan, N.F. Rossi, E.W. Inscho, and D.M. Pollock Regulation of blood pressure and salt homeostasis by endothelin Physiol Rev 91 2011 1 77
103. M.L. Kohut, and D.S. Senchina Reversing age-associated immunosenescence via exercise Exerc Immunol Rev 10 2004 6 41
104. D.H. Korzick, J.M. Muller-Delp, P. Dougherty, C.L. Heaps, D.K. Bowles, and K.K. Krick Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: role of protein kinase C Cardiovasc Res 66 2005 384 392
105. B.K. Krämer, M. Nishida, R.A. Kelly, and T.W. Smith Endothelins. Myocardial actions of a new class of cytokines Circulation 85 1992 350 356
106. M. Kretz, A.L. Mundy, C.C. Widmer, and M. Barton Early aging and anatomic heterogeneity determine cyclooxygenase-mediated vasoconstriction to angiotensin II in mice J Cardiovasc Pharmacol 48 2006 30 33
107. Y. Kurihara, H. Kurihara, H. Suzuki, T. Kodama, K. Maemura, and R. Nagai Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1 Nature 368 1994 703 710
108. Y. Kurihara, H. Kurihara, H. Oda, K. Maemura, R. Nagai, and T. Ishikawa Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1 J Clin Invest 96 1995 293 300
109. M. Kuro-o, Y. Matsumura, H. Aizawa, H. Kawaguchi, T. Suga, and T. Utsugi Mutation of the mouse klotho gene leads to a syndrome resembling ageing Nature 390 1997 45 51
110. H. Kurosu, M. Yamamoto, J.D. Clark, J.V. Pastor, A. Nandi, and P. Gurnani Suppression of aging in mice by the hormone Klotho Science 309 2005 1829 1833
111. E.G. Lakatta Do hypertension and aging have a similar effect on the myocardium? Circulation 75 1987 I69 I77
112. E.G. Lakatta Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging Circulation 107 2003 490 497
113. E.G. Lakatta, J.H. Mitchell, A. Pomerance, and G.G. Rowe Human aging: changes in structure and function J Am Coll Cardiol 10 1987 42A 47A
114. T. Lattmann, M. Hein, S. Horber, J. Ortmann, M.M. Teixeira, and D.G. Souza Activation of pro-inflammatory and anti-inflammatory cytokines in host organs during chronic allograft rejection: role of endothelin receptor signaling Am J Transplant 5 2005 1042 1049
115. T. Lattmann, S. Shaw, K. Munter, W. Vetter, and M. Barton Anatomically distinct activation of endothelin-3 and the l-arginine/nitric oxide pathway in the kidney with advanced aging Biochem Biophys Res Commun 327 2005 234 241
116. U. Laufs, N. Werner, A. Link, M. Endres, S. Wassmann, and K. Jurgens Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis Circulation 109 2004 220 226
117. J. Liu, X. Sui, C.J. Lavie, H. Zhou, Y.M. Mark Park, and B. Cai Effects of cardiorespiratory fitness on nlood pressure trajectory with Aging in a cohort of healthy men J Am Coll Cardiol 64 2014 1245 1253
118. R.A. Lobo, S.R. Davis, T.J. De Villiers, A. Gompel, V.W. Henderson, and H.N. Hodis Prevention of diseases after menopause Climacteric 2014 1 17
119. C. Loffler, H. Kaduszkiewicz, C.O. Stolzenbach, W. Streich, A. Fuchs, and H. van den Bussche Coping with multimorbidity in old age - a qualitative study BMC Fam Pract 13 2012 45
120. M. Löhn, G. Dubrovska, B. Lauterbach, F.C. Luft, M. Gollasch, and A.M. Sharma Periadventitial fat releases a vascular relaxing factor FASEB J 16 2002 1057 1063
121. T.F. Luscher, and M. Barton Biology of the endothelium Clin Cardiol 20 1997 [II-3-10]
122. L.J. Ma, S. Nakamura, J.S. Whitsitt, C. Marcantoni, J.M. Davidson, and A.B. Fogo Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1 Kidney Int 58 2000 2425 2436
123. S. Maeda, T. Tanabe, T. Miyauchi, T. Otsuki, J. Sugawara, and M. Iemitsu Aerobic exercise training reduces plasma endothelin-1 concentration in older women J Appl Physiol (1985) 95 2003 336 341
124. T. Matsumoto, R.A.M. Lopes, K. Taguchi, T. Kobayashi, and R.C. Tostes Linking the beneficial effects of current therapeutic approaches in diabetes to the vascular endothelin system Life Sci 118 2014 129 135 [in this issue]
125. H. Matsushita, E. Chang, A.J. Glassford, J.P. Cooke, C.P. Chiu, and P.S. Tsao eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization Circ Res 89 2001 793 798
126. C.M. McEniery, Yasmin, I.R. Hall, A. Qasem, I.B. Wilkinson, and J.R. Cockcroft Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT) J Am Coll Cardiol 46 2005 1753 1760
127. E.M. Mercken, E. Majounie, J. Ding, R. Guo, J. Kim, and M. Bernier Age-associated miRNA alterations in skeletal muscle from rhesus monkeys reversed by caloric restriction Aging (Albany NY) 5 2013 692 703
128. E.M. Mercken, S.D. Crosby, D.W. Lamming, L. JeBailey, S. Krzysik-Walker, and D.T. Villareal Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile Aging Cell 12 2013 645 651
129. M.A. Merideth, L.B. Gordon, S. Clauss, V. Sachdev, A.C. Smith, and M.B. Perry Phenotype and course of Hutchinson-Gilford progeria syndrome N Engl J Med 358 2008 592 604
130. M.R. Meyer, N.C. Fredette, M. Barton, and E.R. Prossnitz Regulation of vascular smooth muscle tone by adipose-derived contracting factor PLoS One 8 2013 e79245
131. M.R. Meyer, M. Barton, and E.R. Prossnitz Functional heterogeneity of NADPH oxidase-mediated contractions to endothelin with vascular aging Life Sci 118 2014 226 231 [in this issue-a]
132. M.R. Meyer, N.C. Fredette, M. Barton, and E.R. Prossnitz Endothelin-1 but not angiotensin II contributes to functional aging in murine carotid arteries Life Sci 118 2014 213 218 [in this issue-b]
133. M. Michaud, L. Balardy, G. Moulis, C. Gaudin, C. Peyrot, and B. Vellas Proinflammatory cytokines, aging, and age-related diseases J Am Med Dir Assoc 14 2013 877 882
134. A.P. Millar Exercise for the elderly Aust Fam Physician 13 1984 592 593
135. K. Miyagawa, and N. Emoto Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension Ther Adv Cardiovasc Dis 8 2014 202 216
136. R. Moeller-Gorman Endothelin: still beyond reach Proto Magazine 4 2010 Massachusetts General Hospital Boston 24 29 [available at: http://protomag.com/statics/p.-9-endothelin.pdf ]
137. A.H. Mokdad, J.S. Marks, D.F. Stroup, and J.L. Gerberding Actual causes of death in the United States, 2000 JAMA 291 2004 1238 1245
138. S. Moncada, and V.R. Vane Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin Pharmacol Rev 30 1979 293 331
139. S. Moncada, R. Gryglewski, S. Bunting, and J.R. Vane An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation Nature 263 1976 663 665
140. E. Montecino-Rodriguez, B. Berent-Maoz, and K. Dorshkind Causes, consequences, and reversal of immune system aging J Clin Invest 123 2013 958 965
141. C. Moreau, R. Lariviere, I. Kingma, J.H. Grose, and M. Lebel Chronic nitric oxide inhibition aggravates hypertension in erythropoietin-treated renal failure rats Clin Exp Hypertens 22 2000 663 674
142. Y. Mukai, H. Shimokawa, M. Higashi, K. Morikawa, T. Matoba, and J. Hiroki Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats Arterioscler Thromb Vasc Biol 22 2002 1445 1450
143. D. Muñoz-Espín, M. Cañamero, A. Maraver, G. Gómez-López, J. Contreras, and S. Murillo-Cuesta Programmed cell senescence during mammalian embryonic development Cell 155 2013 1104 1118
144. E.G. Nabel Cardiovascular insights from a premature aging syndrome: a translational story Trans Am Clin Climatol Assoc 123 2012 221 225 [discussion 5-6]
145. S.S. Najjar, A. Scuteri, and E.G. Lakatta Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 46 2005 454 462
146. C.B. Newgard, and N.E. Sharpless Coming of age: molecular drivers of aging and therapeutic opportunities J Clin Invest 123 2013 946 950
147. A.B. Newman, A.M. Arnold, B.L. Naydeck, L.P. Fried, G.L. Burke, and P. Enright "Successful aging": effect of subclinical cardiovascular disease Arch Intern Med 163 2003 2315 2322
148. B. Nilius, D.N. Serban, P.M. Vanhoutte, and F. Robert Furchgott and his heritage: endothelial vasomotor control Pflugers Arch 459 2010 787 792
149. D. Nunan, K.R. Mahtani, N. Roberts, and C. Heneghan Physical activity for the prevention and treatment of major chronic disease: an overview of systematic reviews Syst Rev 2 2013 56
150. R.F. O'Brien, R.J. Robbins, and I.F. McMurtry Endothelial cells in culture produce a vasoconstrictor substance J Cell Physiol 132 1987 263 270
151. G. Olivetti, M. Melissari, J.M. Capasso, and P. Anversa Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy Circ Res 68 1991 1560 1568
152. M.F. O'Rourke, and J. Hashimoto Mechanical factors in arterial aging: a clinical perspective J Am Coll Cardiol 50 2007 1 13
153. J. Ortmann, K. Amann, R.P. Brandes, M. Kretzler, K. Munter, and N. Parekh Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition Hypertension 44 2004 974 981
154. R.M. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526
155. S. Payne 19th century Mexican revolution 'fighter' Leandra Becerra Lumbreras becomes oldest person in world September 1, 2014 International Business Times [Available at: http://www.ibtimes.co.uk/19th-century-mexican-revolution-fighter-leandra-becerra-lumbreras-becomes-oldest-person-world-1463473 ]
156. G. Perez-Rivero, M.P. Ruiz-Torres, J.V. Rivas-Elena, M. Jerkic, M.L. Diez-Marques, and J.M. Lopez-Novoa Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production Circulation 114 2006 309 317
157. S. Placier, J.J. Boffa, J.C. Dussaule, and C. Chatziantoniou Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice Nephrol Dial Transplant 21 2006 881 888
158. V. Prasad, and A. Vandross Cardiovascular primary prevention: how high should we set the bar? Arch Intern Med 172 2012 656 659 [discussion 9]
159. S. Rajagopalan, R. Brook, R.H. Mehta, M. Supiano, and B. Pitt Effect of losartan in aging-related endothelial impairment Am J Cardiol 89 2002 562 566
160. T.N. Raju The Nobel chronicles. 1998: Robert Francis Furchgott (b 1911), Louis J Ignarro (b 1941), and Ferid Murad (b 1936) Lancet 356 2000 346
161. F. Rodriguez-Pascual, O. Busnadiego, and J. Gonzalez-Santamaria The profibrotic role of endothelin-1: Is the door still open for the treatment of fibrotic diseases? Life Sci 118 2014 156 164 [in this issue]
162. R. Ross, and J.A. Glomset Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis Science 180 1973 1332 1339
163. G.M. Rubanyi The discovery of endothelin: the power of bioassay and the role of serendipity in the discovery of endothelium-derived vasoactive substances Pharmacol Res 63 2011 448 454
164. J.M. Sasser, J.C. Sullivan, J.L. Hobbs, T. Yamamoto, D.M. Pollock, and P.K. Carmines Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism J Am Soc Nephrol 18 2007 143 154
165. M. Sawabe Vascular aging: from molecular mechanism to clinical significance Geriatr Gerontol Int 10 Suppl. 1 2010 S213 S220
166. V. Schächinger, M.B. Britten, and A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906
167. E.L. Schiffrin Immune mechanisms in hypertension and vascular injury Clin Sci (Lond) 126 2014 267 274
168. M.P. Schneider, E.I. Boesen, and D.M. Pollock Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease Annu Rev Pharmacol Toxicol 47 2007 731 759
169. D.S. Senchina, and M.L. Kohut Immunological outcomes of exercise in older adults Clin Interv Aging 2 2007 3 16
170. W.C. Sessa, S. Kaw, M. Hecker, and J.R. Vane The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes Biochem Biophys Res Commun 174 1991 613 618
171. W.C. Sessa, S. Kaw, A. Zembowicz, E. Anggard, M. Hecker, and J.R. Vane Human polymorphonuclear leukocytes generate and degrade endothelin-1 by two distinct neutral proteases J Cardiovasc Pharmacol 17 Suppl. 7 1991 S34 S38
172. R.J. Simpson, C. Cosgrove, M.M. Chee, B.K. McFarlin, D.B. Bartlett, and G. Spielmann Senescent phenotypes and telomere lengths of peripheral blood T-cells mobilized by acute exercise in humans Exerc Immunol Rev 16 2010 40 55
173. G. Spielmann, B.K. McFarlin, D.P. O'Connor, P.J. Smith, H. Pircher, and R.J. Simpson Aerobic fitness is associated with lower proportions of senescent blood T-cells in man Brain Behav Immun 25 2011 1521 1529
174. M. Storer, A. Mas, A. Robert-Moreno, M. Pecoraro, M.C. Ortells, and V. Di Giacomo Senescence is a developmental mechanism that contributes to embryonic growth and patterning Cell 155 2013 1119 1130
175. Swedish National Institute of Public Health Physical activity in the prevention and treatment of disease Swedish National Institute of Public Health 2010 Available at: http://www.fyss.se/wp-content/uploads/2011/02/fyss-2010-english.pdf 2010 [accessed September 10, 2014]
176. S. Taddei, A. Virdis, P. Mattei, L. Ghiadoni, C.B. Fasolo, and I. Sudano Hypertension causes premature aging of endothelial function in humans Hypertension 29 1997 736 743
177. D.H. Thijssen, G.A. Rongen, A. van Dijk, P. Smits, and M.T. Hopman Enhanced endothelin-1-mediated leg vascular tone in healthy older subjects J Appl Physiol (1985) 103 2007 852 885
178. M.L. Thoman, and W.O. Weigle The cellular and subcellular bases of immunosenescence Adv Immunol 46 1989 221 261
179. P.D. Thompson, D. Buchner, I.L. Pina, G.J. Balady, M.A. Williams, and B.H. Marcus Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity) Circulation 107 2003 3109 3116
180. M. Tonelli, and M. Riella Chronic kidney disease and the aging population Clin Nephrol 81 2014 192 197
181. R.M. Touyz, R. Lariviere, and E.L. Schiffrin Endothelin influences pHi of human platelets through protein kinase C mediated pathways Thromb Res 78 1995 55 65
182. T. Traupe, J. Ortmann, K. Munter, and M. Barton Endothelial therapy of atherosclerosis and its risk factors Curr Vasc Pharmacol 1 2003 111 121
183. M.R. Tschudi, M. Barton, N.A. Bersinger, P. Moreau, F. Cosentino, and G. Noll Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery J Clin Invest 98 1996 899 905
184. U.S. Census Bureau Global population composition 2002 U.S. Census Bureau, International Programs Center, International Data Base. Bureau of the Census, U.S. Department of Commerce Washington, D.C. [ http://www.census.gov/population/international/files/wp02/wp-02004.pdf [accessed August 14, 2014]]
185. G.P. Van Guilder, C.M. Westby, J.J. Greiner, B.L. Stauffer, and C.A. DeSouza Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise Hypertension 50 2007 403 409
186. M. Vasa, K. Breitschopf, A.M. Zeiher, and S. Dimmeler Nitric oxide activates telomerase and delays endothelial cell senescence Circ Res 87 2000 540 542
187. A. Virdis, L. Ghiadoni, S. Masi, D. Versari, E. Daghini, and C. Giannarelli Obesity in the childhood: a link to adult hypertension Curr Pharm Des 15 2009 1063 1071
188. Y. Wang, and Z. Sun Antiaging gene Klotho regulates endothelin-1 levels and endothelin receptor subtype B expression in kidneys of spontaneously hypertensive rats J Hypertens 32 2014 1629 1636 [discussion 36]
189. M. Wang, J. Zhang, L.Q. Jiang, G. Spinetti, G. Pintus, and R. Monticone Proinflammatory profile within the grossly normal aged human aortic wall Hypertension 50 2007 219 227
190. C.Y. Wang, H.H. Kim, Y. Hiroi, N. Sawada, S. Salomone, and L.E. Benjamin Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR Sci Signal 2 2009 ra11
191. C. Werner, M. Hanhoun, T. Widmann, A. Kazakov, A. Semenov, and J. Poss Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis J Am Coll Cardiol 52 2008 470 482
192. C. Werner, T. Furster, T. Widmann, J. Poss, C. Roggia, and M. Hanhoun Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall Circulation 120 2009 2438 2447
193. B.J. Whittle, and S. Moncada The endothelin explosion. A pathophysiological reality or a biological curiosity? Circulation 81 1990 2022 2025
194. WHO Recommendations Global recommendations on physical activity for health 2010 WHO Geneva, Switzerland [Available at: http://whqlibdoc.who.int/publications/2010/9789241599979-eng.pdf ]
195. C.C. Widmer, A.L. Mundy, M. Kretz, and M. Barton Marked heterogeneity of endothelin-mediated contractility and contraction dynamics in mouse renal and femoral arteries Exp Biol Med (Maywood) 231 2006 777 781
196. H. Wienbergen, and R. Hambrecht Physical exercise and its effects on coronary artery disease Curr Opin Pharmacol 13 2013 218 225
197. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, and Y. Mitsui A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
198. H. Yang, and A.B. Fogo Cell senescence in the aging kidney J Am Soc Nephrol 21 2010 1436 1439
199. M. Yoshibayashi, K. Nishioka, K. Nakao, Y. Saito, S. Temma, and M. Matsumura Plasma endothelin levels in healthy children: high values in early infancy J Cardiovasc Pharmacol 17 Suppl. 7 1991 S404 S405
200. W.A. Zoghbi, T. Duncan, E. Antman, M. Barbosa, B. Champagne, and D. Chen Sustainable development goals and the future of cardiovascular health: a statement from the global cardiovascular disease taskforce J Am Heart Assoc 3 2014 e000504
201. Z. Zuo, H. Lei, X. Wang, Y. Wang, W. Sonntag, and Z. Sun Aging-related kidney damage is associated with a decrease in klotho expression and an increase in superoxide production Age (Dordr) 33 2011 261 274